Juan P. Alderuccio, Md

This early-stage trial tests whether adding the targeted drug zanubrutinib to a standard chemotherapy regimen (Pola-R-CHP plus high-dose methotrexate) is safe for people with large B-cell lymphoma that has spread to the central nervous system (brain or spinal cord). About 20 adul…

This Phase 2 trial is testing whether a combination of two drugs—loncastuximab tesirine and rituximab—can shrink or eliminate tumors in people with follicular lymphoma that has come back or not responded to previous treatment. About 100 adults will receive the drugs through an IV…